BXTAccelyon blog

October 14, 2019

Stephen McMahon (Queen's University Research Fellow, Queen's University Belfast)

26 July 2019

High energy proton beam therapy, an advanced form of radiotherapy, made its debut in the UK in 2018. Both the NHS and private clinics began offering this treatment in the same year, but they treated very different patient groups. While the NHS used the therapy to treat childhood cancer, private clinics began treating men with prostate c...

August 6, 2019

All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy.

That’s the current recommendation from the National Institute for Health and Care Excellence (NICE) in its latest guidelines.

This special type of imaging, called multiparametric (mp)MRI, combines three different scans to help build a clearer picture of what’s going on in the prostate....

August 6, 2019

Forget Brexit, it’s all about TRexit – and urology nurses are leading the way

Jonah Rusere, Advanced Nurse Practitioner for South East London Accountable Cancer Network, outlines an opportunity for urology nurses to make a difference to prostate cancer pathways.

Everyone knows that Brexit didn’t happen on the 29th March, 2019. But ‘TRexit’ did – and it’s great news for prostate cancer patients all over the country. Confused? Let...

July 30, 2019

The National Prostate Cancer Audit (NPCA) published results from a prospective audit of men newly diagnosed with prostate cancer earlier this year. Men diagnosed with prostate cancer in England and Wales between 1st April 2016 and 31st March 2017 were included in the audit.

Recommendations from the findings included increased use of transperineal prostate biopsy. The report noted that the use of transperineal biopsies had remai...

July 8, 2019

A new study published in the International Multidisciplinary Brachytherapy Journal entitled Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) has found that patients who underwent low dose rate brachytherapy displayed acceptable and comparable levels of genitourinary (GU) toxicity to those previously repo...

July 1, 2019

The team at BXTAccelyon is delighted to welcome Kalpesh as the latest addition to its number.

Kalpesh is an experienced Clinical Application Specialist, having previously worked in a similar role across the Midlands area. There he implemented a number of departmental policies and procedures, and provided ultrasound training and applications support in a number of clinical areas.

Kalpesh is passionate about healthcare. As part of...

The customer services team at BXTAccelyon has gone from strength to strength over the last 12 months. Recent contract wins have increased demand for the service that currently operates in 13 countries internationally. The highly knowledgeable team of four provide an exemplary service for our customers that goes way beyond what you’d expect from the average customer service team.

The team, Avni, Katrin, Lucy and Mark, are season...

May 14, 2019

BXTAccelyon has responded to an article on the Daily Mail that claims that a ten-minute shot of High Dose-Rate (HDR) radiation treatment is a “safe and effective” choice for low-risk prostate cancer patients.

The article reports that a three year study of prostate cancer patients from the Christie Hospital in Manchester and Mount Vernon in London claims that a one-hit treatment of HDR brachytherapy cuts the risk of side-effects...

March 27, 2019

Prostate cancer remains the most common male cancer in Scotland, accounting for more than 20% of all cancers diagnosed in men. It is the largest cause of male cancer deaths. Although the number of cases per year of prostate cancer has largely stayed the same in the past decade, survival rates are improving, particularly where diagnosis is early. The development of new technologies and treatments has undoubtedly contributed to...

March 22, 2019

In 1976 Chris successfully underwent an orchidectomy followed by external beam radiation therapy (ERBT) to remove his testicular cancer. Fast forward to 2016 and Chris began experiencing urinary incontinence, with an increased urge to go at night time. Having experienced similar symptoms during his first cancer diagnosis, he visited his GP to get checked. Following standard tests, his GP referred him to the Urology department...

Please reload

Recent Posts
Please reload

Archive